Diabetic Cardiomyopathy: Current and Future Therapies. Beyond Glycemic Control
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Diabetic Cardiomyopathy: Current and Future Therapies. Beyond Glycemic Control
Authors
Keywords
-
Journal
Frontiers in Physiology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-10-30
DOI
10.3389/fphys.2018.01514
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Do DPP-4 Inhibitors Cause Heart Failure Events by Promoting Adrenergically Mediated Cardiotoxicity?Novelty and Significance
- (2018) Milton Packer CIRCULATION RESEARCH
- Diabetes-Induced Cardiomyocyte Passive Stiffening Is Caused by Impaired Insulin-Dependent Titin Modification and Can Be Modulated by Neuregulin-1Novelty and Significance
- (2018) Anna-Eliane Hopf et al. CIRCULATION RESEARCH
- Diabetic Cardiomyopathy
- (2018) Guanghong Jia et al. CIRCULATION RESEARCH
- MECHANISMS IN ENDOCRINOLOGY: Diabetic cardiomyopathy: pathophysiology and potential metabolic interventions state of the art review
- (2018) Eylem Levelt et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Direct cardiovascular impact of SGLT2 inhibitors: mechanisms and effects
- (2018) Abdullah Kaplan et al. HEART FAILURE REVIEWS
- Mitochondrial proteome disruption in the diabetic heart through targeted epigenetic regulation at the mitochondrial heat shock protein 70 (mtHsp70) nuclear locus
- (2018) Danielle L. Shepherd et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Emerging Actors in Diabetic Cardiomyopathy: Heartbreaker Biomarkers or Therapeutic Targets?
- (2018) Xavier Palomer et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Nanomedicines as emerging platform for simultaneous delivery of cancer therapeutics: new developments in overcoming drug resistance and optimizing anticancer efficacy
- (2018) Zahid Hussain et al. Artificial Cells Nanomedicine and Biotechnology
- Diabetic Cardiomyopathy: Impact of Biological Sex on Disease Development and Molecular Signatures
- (2018) Ryan Toedebusch et al. Frontiers in Physiology
- The Big Entity of New RNA World: Long Non-Coding RNAs in Microvascular Complications of Diabetes
- (2018) Satish K. Raut et al. Frontiers in Endocrinology
- Type 2 Diabetes Mellitus and Cardiovascular Disease: Genetic and Epigenetic Links
- (2018) Salvatore De Rosa et al. Frontiers in Endocrinology
- The potential role and rationale for treatment of heart failure with sodium-glucose co-transporter 2 inhibitors
- (2017) Javed Butler et al. EUROPEAN JOURNAL OF HEART FAILURE
- Perfusion CT – A novel quantitative and qualitative imaging biomarker in gastric cancer
- (2017) Joanna Kruk-Bachonko et al. EUROPEAN JOURNAL OF RADIOLOGY
- The influence of anti-hyperglycemic drug therapy on cardiovascular and heart failure outcomes in patients with type 2 diabetes mellitus
- (2017) Rabea Asleh et al. HEART FAILURE REVIEWS
- Perspectives on cardiovascular effects of incretin-based drugs: From bedside to bench, return trip
- (2017) Michaela Luconi et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Cardiac proteasome functional insufficiency plays a pathogenic role in diabetic cardiomyopathy
- (2017) Jie Li et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- miR-146a mediates inflammatory changes and fibrosis in the heart in diabetes
- (2017) Biao Feng et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
- (2017) Rury R. Holman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
- (2017) Bruce Neal et al. NEW ENGLAND JOURNAL OF MEDICINE
- lncRNA MIAT functions as a competing endogenous RNA to upregulate DAPK2 by sponging miR-22-3p in diabetic cardiomyopathy
- (2017) Xiang Zhou et al. Cell Death & Disease
- Serum microRNA-1 and microRNA-133a levels reflect myocardial steatosis in uncomplicated type 2 diabetes
- (2017) D. de Gonzalo-Calvo et al. Scientific Reports
- New Antihyperglycemic Drugs and Heart Failure: Synopsis of Basic and Clinical Data
- (2017) Dirk von Lewinski et al. Biomed Research International
- Diabetic Cardiomyopathy: Current Approach and Potential Diagnostic and Therapeutic Targets
- (2017) Georgiana-Emmanuela Gilca et al. Journal of Diabetes Research
- Diabetic cardiomyopathy: where we are and where we are going
- (2017) Wang-Soo Lee et al. KOREAN JOURNAL OF INTERNAL MEDICINE
- Major adverse cardiovascular event reduction with GLP-1 and SGLT2 agents: evidence and clinical potential
- (2017) Michael E. Røder Therapeutic Advances in Chronic Disease
- Evaluation and diagnostic potential of circulating extracellular vesicle-associated microRNAs in adrenocortical tumors
- (2017) Pál Perge et al. Scientific Reports
- Circulating miR-19b and miR-181b are potential biomarkers for diabetic cardiomyopathy
- (2017) Camila Uribe Copier et al. Scientific Reports
- CV Protection in the EMPA-REG OUTCOME Trial: A “Thrifty Substrate” Hypothesis
- (2016) Ele Ferrannini et al. DIABETES CARE
- Empagliflozin decreases myocardial cytoplasmic Na+ through inhibition of the cardiac Na+/H+ exchanger in rats and rabbits
- (2016) Antonius Baartscheer et al. DIABETOLOGIA
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
- (2016) Piotr Ponikowski et al. EUROPEAN HEART JOURNAL
- Effect of dipeptidyl peptidase-4 inhibitors on heart failure: A meta-analysis of randomized clinical trials
- (2016) J. Kongwatcharapong et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Effects of Dipeptidyl Peptidase 4 Inhibitors and Sodium-Glucose Linked coTransporter-2 Inhibitors on cardiovascular events in patients with type 2 diabetes mellitus: A meta-analysis
- (2016) Gianluigi Savarese et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Involvement of long noncoding RNA MALAT1 in the pathogenesis of diabetic cardiomyopathy
- (2016) Mengyao Zhang et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Telemonitoring in heart failure patients treated by cardiac resynchronisation therapy with defibrillator (CRT-D): the TELECART Study
- (2016) C. Sardu et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Diabetic Cardiomyopathy: Does the Type of Diabetes Matter?
- (2016) Maximilian Hölscher et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Diabetes-associated cardiac fibrosis: Cellular effectors, molecular mechanisms and therapeutic opportunities
- (2016) Ilaria Russo et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- The Emerging Role of Metabolomics in the Diagnosis and Prognosis of Cardiovascular Disease
- (2016) John R. Ussher et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- miR-30c and miR-181a synergistically modulate p53–p21 pathway in diabetes induced cardiac hypertrophy
- (2016) Satish K. Raut et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Caveolin 1 Modulates Aldosterone‐Mediated Pathways of Glucose and Lipid Homeostasis
- (2016) Rene Baudrand et al. Journal of the American Heart Association
- Cardiac Resynchronization Therapy Outcomes in Type 2 Diabetic Patients: Role of MicroRNA Changes
- (2016) Celestino Sardu et al. Journal of Diabetes Research
- Circulating long-non coding RNAs as biomarkers of left ventricular diastolic function and remodelling in patients with well-controlled type 2 diabetes
- (2016) D. de Gonzalo-Calvo et al. Scientific Reports
- Upregulation of MG53 Induces Diabetic Cardiomyopathy Through Transcriptional Activation of Peroxisome Proliferation-Activated Receptor
- (2015) F. Liu et al. CIRCULATION
- Inhibition of Dipeptidyl Peptidase-4 Impairs Ventricular Function and Promotes Cardiac Fibrosis in High Fat–Fed Diabetic Mice
- (2015) Erin E. Mulvihill et al. DIABETES
- SGLT-2 inhibitors and cardiovascular risk: Proposed pathways and review of ongoing outcome trials
- (2015) Silvio E Inzucchi et al. Diabetes & Vascular Disease Research
- MicroRNA profiling unveils hyperglycaemic memory in the diabetic heart
- (2015) Sarah Costantino et al. EUROPEAN HEART JOURNAL
- Exenatide exerts a PKA-dependent positive inotropic effect in human atrial myocardium
- (2015) Markus Wallner et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- The Use of SGLT-2 Inhibitors in Type 2 Diabetes and Heart Failure
- (2015) Kayla Riggs et al. Metabolic Syndrome and Related Disorders
- Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion
- (2015) Caroline Bonner et al. NATURE MEDICINE
- Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy
- (2015) Guanghong Jia et al. Nature Reviews Endocrinology
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes
- (2015) Jennifer B. Green et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
- (2015) Marc A. Pfeffer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Stimulation of glucagon-like peptide-1 receptor through exendin-4 preserves myocardial performance and prevents cardiac remodeling in infarcted myocardium
- (2014) Megan DeNicola et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Diabetic Basement Membrane Thickening Does Not Occur in Myocardial Capillaries of Transgenic Mice When Metallothionein is Overexpressed in Cardiac Myocytes
- (2014) ANA Velic et al. Anatomical Record-Advances in Integrative Anatomy and Evolutionary Biology
- Pharmacology, Physiology, and Mechanisms of Action of Dipeptidyl Peptidase-4 Inhibitors
- (2014) Erin E. Mulvihill et al. ENDOCRINE REVIEWS
- GLP-1 Receptor Localization in Monkey and Human Tissue: Novel Distribution Revealed With Extensively Validated Monoclonal Antibody
- (2014) Charles Pyke et al. ENDOCRINOLOGY
- Sulforaphane prevents the development of cardiomyopathy in type 2 diabetic mice probably by reversing oxidative stress-induced inhibition of LKB1/AMPK pathway
- (2014) Zhiguo Zhang et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Effects of sodium-glucose co-transporter 2 inhibitors on blood pressure: A systematic review and meta-analysis
- (2014) William L. Baker et al. Journal of the American Society of Hypertension
- Dipeptidyl peptidase inhibition prevents diastolic dysfunction and reduces myocardial fibrosis in a Mouse model of Western diet induced obesity
- (2014) Brian Bostick et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Diabetic cardiomyopathy: Mechanisms and new treatment strategies targeting antioxidant signaling pathways
- (2014) Karina Huynh et al. PHARMACOLOGY & THERAPEUTICS
- Dipeptidyl-peptidase IV inhibition improves pathophysiology of heart failure and increases survival rate in pressure-overloaded mice
- (2013) Ayako Takahashi et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Defective Nrf2-dependent redox signalling contributes to microvascular dysfunction in type 2 diabetes
- (2013) Gopal V. Velmurugan et al. CARDIOVASCULAR RESEARCH
- Circulating Dipeptidyl Peptidase IV Activity Correlates With Cardiac Dysfunction in Human and Experimental Heart Failure
- (2013) Leonardo dos Santos et al. Circulation-Heart Failure
- Identification and Characterization of GLP-1 Receptor-Expressing Cells Using a New Transgenic Mouse Model
- (2013) P. Richards et al. DIABETES
- Circulating microRNA changes in heart failure patients treated with cardiac resynchronization therapy: responders vs. non-responders
- (2013) Raffaele Marfella et al. EUROPEAN JOURNAL OF HEART FAILURE
- Targeting the upregulation of reactive oxygen species subsequent to hyperglycemia prevents type 1 diabetic cardiomyopathy in mice
- (2013) Karina Huynh et al. FREE RADICAL BIOLOGY AND MEDICINE
- Metabolic dysfunction in diabetic cardiomyopathy
- (2013) Michael Isfort et al. HEART FAILURE REVIEWS
- Identifying Natural Substrates for Dipeptidyl Peptidases 8 and 9 Using Terminal Amine Isotopic Labeling of Substrates (TAILS) Revealsin VivoRoles in Cellular Homeostasis and Energy Metabolism
- (2013) Claire H. Wilson et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cardioprotective effects of lixisenatide in rat myocardial ischemia-reperfusion injury studies
- (2013) Paulus Wohlfart et al. Journal of Translational Medicine
- GLP-1 receptor activation and Epac2 link atrial natriuretic peptide secretion to control of blood pressure
- (2013) Minsuk Kim et al. NATURE MEDICINE
- Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
- (2013) William B. White et al. NEW ENGLAND JOURNAL OF MEDICINE
- Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
- (2013) Benjamin M. Scirica et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dipeptidyl Peptidase-4 Modulates Left Ventricular Dysfunction in Chronic Heart Failure via Angiogenesis-Dependent and -Independent Actions
- (2012) Toshimasa Shigeta et al. CIRCULATION
- Insulin resistance improves metabolic and contractile efficiency in stressed rat heart
- (2012) Romain Harmancey et al. FASEB JOURNAL
- Diabetic cardiomyopathy: pathophysiology and clinical features
- (2012) Takayuki Miki et al. HEART FAILURE REVIEWS
- Myocardial substrate metabolism in obesity
- (2012) O J Rider et al. INTERNATIONAL JOURNAL OF OBESITY
- Dipeptidyl Peptidase 4 Inhibition Increases Myocardial Glucose Uptake in Nonischemic Cardiomyopathy
- (2012) Ronald M. Witteles et al. JOURNAL OF CARDIAC FAILURE
- Metabolic stress–induced activation of FoxO1 triggers diabetic cardiomyopathy in mice
- (2012) Pavan K. Battiprolu et al. JOURNAL OF CLINICAL INVESTIGATION
- Molecular and metabolic mechanisms of cardiac dysfunction in diabetes
- (2012) Chirag H. Mandavia et al. LIFE SCIENCES
- GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus
- (2012) Juris J. Meier Nature Reviews Endocrinology
- Glucagon-like peptide-1 activates endothelial nitric oxide synthase in human umbilical vein endothelial cells
- (2011) Li Ding et al. ACTA PHARMACOLOGICA SINICA
- Review: Intracardiac intracellular angiotensin system in diabetes
- (2011) Rajesh Kumar et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Role of advanced glycation end products (AGEs) and oxidative stress in vascular complications in diabetes
- (2011) Sho-ichi Yamagishi et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Intravenous Gene Therapy With PIM-1 Via a Cardiotropic Viral Vector Halts the Progression of Diabetic Cardiomyopathy Through Promotion of Prosurvival Signaling
- (2011) Rajesh Katare et al. CIRCULATION RESEARCH
- Left ventricle structural remodelling in the prediabetic Goto-Kakizaki rat
- (2011) Alicia D'Souza et al. EXPERIMENTAL PHYSIOLOGY
- Increased propensity for cell death in diabetic human heart is mediated by mitochondrial-dependent pathways
- (2010) Ethan J. Anderson et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Glucagon-like peptide-1 and the exenatide analogue AC3174 improve cardiac function, cardiac remodeling, and survival in rats with chronic heart failure
- (2010) Que Liu et al. Cardiovascular Diabetology
- Mitochondria in the diabetic heart
- (2010) H. Bugger et al. CARDIOVASCULAR RESEARCH
- Cardiac-Specific IGF-1 Receptor Transgenic Expression Protects Against Cardiac Fibrosis and Diastolic Dysfunction in a Mouse Model of Diabetic Cardiomyopathy
- (2010) K. Huynh et al. DIABETES
- The Development of Heart Failure in Patients With Diabetes Mellitus and Pre-Clinical Diastolic Dysfunction
- (2010) Aaron M. From et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Severe Hypoglycemia and Risks of Vascular Events and Death
- (2010) Sophia Zoungas et al. NEW ENGLAND JOURNAL OF MEDICINE
- Global estimates of the prevalence of diabetes for 2010 and 2030
- (2009) J.E. Shaw et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Exenatide Reduces Infarct Size and Improves Cardiac Function in a Porcine Model of Ischemia and Reperfusion Injury
- (2009) Leo Timmers et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Therapies for hyperglycaemia-induced diabetic complications: from animal models to clinical trials
- (2009) Nigel A. Calcutt et al. NATURE REVIEWS DRUG DISCOVERY
- Exploiting cGMP-based therapies for the prevention of left ventricular hypertrophy: NO• and beyond
- (2009) Rebecca H. Ritchie et al. PHARMACOLOGY & THERAPEUTICS
- The cAMP binding protein Epac regulates cardiac myofilament function
- (2009) O. Cazorla et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Association Between Diabetes Mellitus and Left Ventricular Hypertrophy in a Multiethnic Population
- (2008) Kazuo Eguchi et al. AMERICAN JOURNAL OF CARDIOLOGY
- Regulation of cardiomyocyte hypertrophy in diabetes at the transcriptional level
- (2008) Biao Feng et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Prevention of Heart Failure
- (2008) Douglas D. Schocken et al. CIRCULATION
- Hemodynamic Effects of Fenofibrate and Coenzyme Q10 in Type 2 Diabetic Subjects With Left Ventricular Diastolic Dysfunction
- (2008) G. T. Chew et al. DIABETES CARE
- The Role of Advanced Glycation End Products in Progression and Complications of Diabetes
- (2008) Su-Yen Goh et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The Relationship of Left Ventricular Mass and Geometry to Incident Cardiovascular Events
- (2008) David A. Bluemke et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Interplay between impaired calcium regulation and insulin signaling abnormalities in diabetic cardiomyopathy
- (2008) Djamel Lebeche et al. Nature clinical practice. Cardiovascular medicine
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started